A new tricarbonyl fac-[M(acac)(isc)(CO)3] complex (M=Re, 99mTc) with acetylacetonate (acac) and isocyanide (isc) in a 2+1 combination

Radiosynthesis and Bioevaluation of 99mTc-Labeled Isocyanide Ubiquicidin 29-41 Derivatives as Potential Agents for Bacterial Infection Imaging

To develop a novel 99mTc-labeled ubiquicidin 29-41 derivative for bacterial infection single-photon emission computed tomography (SPECT) imaging with improved target-to-nontarget ratio and lower nontarget organ uptake, a series of isocyanide ubiquicidin 29-41 derivatives (CNnUBI 29-41, n = 5-9) with different carbon linkers were designed, synthesized and radiolabeled with the [99mTc]Tc(I)+ core, [99mTc][Tc(I)(CO)3(H2O)3]+ core and [99mTc][Tc(V)N]2+ core. All the complexes are hydrophilic, maintain good stability and specifically bind Staphylococcus aureus in vitro. The biodistribution in mice with bacterial infection and sterile inflammation demonstrated that [99mTc]Tc-CN5UBI 29-41 was able to distinguish bacterial infection from sterile inflammation, which had an improved abscess uptake and a greater target-to-nontarget ratio. SPECT imaging study of [99mTc]Tc-CN5UBI 29-41 in bacterial infection mice showed that there was a clear accumulation in the infection site, suggesting that this radiotracer could be a potential radiotracer for bacterial infection imaging.

2 + 1 Tricarbonyl Complexes of Technetium(I) with a Combination of N,N-Bidentate Ligands and Ethyl Isocyanoacetate: How Strong Is the Interfering Effect of Chloride Ions on Their Formation?

Technetium(I) 2 + 1 tricarbonyl complexes with a combination of N,N-bidentate ligands (2,2'-bipyridine, bipy; 1,10-phenanthroline, phen) and ethyl isocyanoacetate were prepared and characterized by NMR, IR, UV/visible, and luminescence spectroscopies and by high-performance liquid chromatography (HPLC). The crystal structures of [99Tc(CO)3(bipy)(CNCH2COOEt)](ClO4) (in the form of a solvate with 0.5CH2Cl2) and [99Tc(CO)3(phen)(CNCH2COOEt)](ClO4) (in the form of an adduct with an outer-sphere phen molecule) were determined by single-crystal X-ray diffraction. To evaluate the interfering effect of chloride ions on the formation of the 2 + 1 complexes, the kinetics of the replacement of labile monodentate ligand X in the complexes [MX(CO)3(N∧N)] (M = Re, 99Tc; N∧N = bipy, phen; X = Cl-, ClO4-) by CNCH2COOEt in ethanol were compared. The 99Tc bipy complexes with X = ClO4- (according to the IR data, perchlorate anion in ethanol is displaced from the coordination sphere by the solvent molecule) and X = Cl- are characterized by close ligand replacement rates. In the case of the 99Tc complexes with phen and Re complexes with both phen and bipy, the chloride complexes are appreciably less reactive than the chloride-free complexes. The technetium complexes are considerably more reactive in ligand replacement than their rhenium analogues. In the chloride-containing medium (saline), the complex [99mTc(CO)3(bipy)(CNCH2COOEt)]+ can be prepared under the conditions acceptable for nuclear medical applications, although higher isonitrile concentrations are required as compared to the chloride-free system.

Effective Labeling of Amine Pharmacophores through the Employment of 2,3-Pyrazinedicarboxylic Anhydride and the Generation of fac-[M(CO)3(PyA)P] and cis-trans-[M(CO)2(PyA)P2] Complexes (PyA = Pyrazine-2-carboxylate, P = Phosphine, M = Re, 99mTc)

The fac-[M(CO)₃(PyA)(P)] and cis-trans-[M(CO)₂(PyA)(P)₂] neutral complexes (M is Re or ^99mTc), based on the mixed ligand strategy with pyrazine-2-carboxylic acid (PyAH) as the bidentate N,O and triphenylphosphine as the monodentate P ligand, are presented. Through the employment of the anhydride of pyrazine-2,3-dicarboxylic acid (PyDA), the PyAH scaffold was conveniently derivatized with the model bioactive amine 1-(2-methoxyphenyl)piperazine, the active part of the 5-HT_1A antagonist WAY100635. Reaction of either PyAH or the pharmacophore-bearing PyAH ligand (L¹H) with fac-[M(CO)₃]⁺ core in water yielded the intermediate fac-[M(CO)₃(PyA)(H₂O)] complexes. The labile aqua ligand was easily replaced by PPh₃ to yield the fac-[Re(CO)₃(PyA)(PPh₃)] complexes, while in toluene under reflux, the cis-trans-[Re(CO)₂(PyA)(PPh₃)₂] complexes were obtained. The latter complexes were alternatively obtained from mer-[Re(CO)₃(PPh₃)₂Cl] by refluxing with the PyA ligand in toluene. The analogous ^99mTc complexes were synthesized quantitatively, showing excellent stability in competition studies. The methodology described herein represents a practical procedure for the effective integration of the fac-[M(CO)₃]⁺ core with amine-bearing biologically active compounds for diagnosis/therapy.

Synthesis and evaluation of new mixed "2 + 1" Re, 99mTc and 186Re tricarbonyl dithiocarbamate complexes with different monodentate ligands

A series of "2 + 1" mixed ligand tricarbonyl complexes of the general formula fac-[Re/^99mTc/¹⁸⁶Re(CO)₃(DDTC)(L)] containing diethyldithiocarbamate (DDTC) as a monoanionic bidentate ligand and a series of monodentate ligands L was synthesized, characterized and evaluated. The impact of ligand L on the radiochemical yield (RCY) and biodistribution of the final compounds was also investigated. DDTC and the appropriate L ligand [cyclohexyl isocyanide (cisc), tert-butyl isocyanide (tbi), triphenylphosphine (PPh₃), methyldiphenylphosphine (PPh₂Me), triphenylarsine (AsPh₃), imidazole (im), and 4-aminopyridine (4AP)] readily reacted in equimolar amounts with the [Et₄N]₂[Re(CO)₃Br₃] precursor to afford fac-[Re(CO)₃(DDTC)(cisc)], Re1, fac-[Re(CO)₃(DDTC)(tbi)], Re2, fac-[Re(CO)₃(DDTC)(PPh₃)], Re3, fac-[Re(CO)₃(DDTC)(PPh₂Me)], Re4, fac-[Re(CO)₃(DDTC)(AsPh₃)], Re5, fac-[Re(CO)₃(DDTC)(im)], Re6 and fac-[Re(CO)₃(DDTC)(4AP)], Re7, complexes in high yields (>80%). All Re complexes were fully characterized by IR, NMR, and in addition Re4, Re5, and Re7 with X-ray crystallography. Analogous reactions as performed with Re were subsequently explored on the ^99mTc and ¹⁸⁶Re-tracer levels using the corresponding fac-[^99mTc/¹⁸⁶Re(CO)₃(H₂O)₃]⁺ precursor. Complexes ^99mTc1 - ^99mTc5, ¹⁸⁶Re1 and ¹⁸⁶Re3 were obtained in high radiochemical yield (>91%), while the complexes ^99mTc6, ^99mTc7 and ¹⁸⁶Re7 formed with radiochemical yields of 55%, 28%, and 75%, respectively. The ^99mTc and ¹⁸⁶Re-complexes were characterized by comparative HPLC analysis using the analogous Re complexes. During histidine and cysteine challenge experiments at 37 °C through 6 h, complexes ^99mTc1 - ^99mTc5 remained > 92% stable, while complexes ^99mTc6 and ^99mTc7 remained only 8% stable through 3 h. Similar studies for ¹⁸⁶Re-complexes showed that ¹⁸⁶Re1 and ¹⁸⁶Re3 remained > 95% stable for up to 48 h, while ¹⁸⁶Re7 had decreased to 7% after 3 h. LogD_7.4 data of ^99mTc1 - ^99mTc5, ¹⁸⁶Re1, and ¹⁸⁶Re3 complexes, which ranged from 2.59 to 3.39, suggested high lipophilicity. Biodistribution studies in healthy Swiss albino mice showed hepatobiliary excretion for ^99mTc1, ^99mTc2, and ^99mTc4, fast blood clearance for ^99mTc4, while high liver uptake and retention for ^99mTc3 and ^99mTc5 were measured. Moreover, ^99mTc2 showed high accumulation in the lungs with sustained retention (52.80% ID/g at 4 h p.i.) and significant brain uptake at 2 min p.i. (1.89% ID/g). The study showed the great influence of monodentate ligand in the synthesis and biodistribution of the mixed ligand complexes.

Complexes of Technetium(V) and Rhenium(V) with β-Diketonates

Reactions of (NBu₄)[MOCl₄] complexes (M = Tc or Re) with an excess of hexafluoroacetylacetone (Hhfac) give products with a composition of (NBu₄)[MOCl₃(hfac)] as bright yellow (Tc) or red (Re) solids. The products are stable as solids but rapidly decompose in solution. A number of related phenylimidorhenium(V) complexes were synthesized starting from [Re(NPhF)Cl₃(PPh₃)₂], where (NPhF)^2- is a para-fluorinated phenylimido ligand. Products with compositions of [Re(NPhF)Cl₂(PPh₃)(acac)], [Re(NPhF)Cl₂(PPh₃)(hfac)], [Re(NPhF)Cl₂(PPh₃)(tfac)], [Re(NPhF)Cl₂(PPh₃)(naphtfac)], and [Re(NPhF)Cl₂(PPh₃)(^tbutfac)] (Hacac = acetylacetone, Htfac = trifluoroacetylacetone, Hnaphtfac = naphthoyltrifluoroacetylmethane, and H^tbutfac = tert-butyroyltrifluoroacetylmethane) were isolated from reactions of the quite soluble [Re(NPhF)Cl₃(PPh₃)₂] with the corresponding β-diketones and studied spectroscopically and by X-ray diffraction. The β-diketonates are coordinated in a meridional arrangement with the phenylimide. The formation of two isomers was detected for nonsymmetric β-diketones with a preference for the "equatorial" position for the more bulky substituents. Products with more than one chelating ligand were not obtained. The technetium complexes [Tc(NPhX)Cl₃(PPh₃)₂] (X = p-F or p-CF₃) were prepared from reactions of pertechnetate, PPh₃, HCl, and substituted arylacetylhydrazines and isolated as green solids. They are sufficiently stable as solid but rapidly decompose in moist solvents upon hydrolysis of the Tc-N bonds. From reactions of [Tc(NPh)Cl₃(PPh₃)₂] or [Tc(NPhF)Cl₃(PPh₃)₂] in dry solvents, the complexes [Tc(NPh)Cl₂(PPh₃)(hfac)] and [Tc(NPhF)Cl₂(PPh₃)(hfac)] were prepared and isolated in crystalline form. An X-ray diffraction study shows that fluorination of the para position of the phenylimido ligand results in a slight lengthening of all bonds in the coordination sphere of technetium.

Dicarbonyl cis-[M(CO)2(N,O)(C)(P)] (M = Re, 99mTc) Complexes with a New [2 + 1 + 1] Donor Atom Combination

The synthesis and characterization of the dicarbonyl mixed ligand cis-[Re(CO)₂(quin)(cisc)(PPh₃)] complex, 4, where quin is the deprotonated quinaldic acid, cisc is cyclohexyl isocyanide, and PPh₃ is triphenylphosphine, is presented. The synthesis of 4 proceeds in three steps. In the first, the intermediate fac-[Re(CO)₃(quin)(H₂O)] aqua complex 2 is generated from the fac-[NEt₄]₂[Re(CO)₃Br₃] precursor, together with the brominated products fac-[Re(CO)₃(quinH)(Br)] 1a and fac-[NEt₄][Re(CO)₃(quin)(Br)] 1b, in low yield. In the following step, replacement of the aqua ligand of complex 2 by the monodentate isocyanide ligand leads to the formation of fac-[Re(CO)₃(quin)(cisc)], 3. In the third step replacement of the species trans to the isocyanide carbonyl group of 3 by a phosphine generates complex 4. The Re complexes 2-4 were prepared in high yield and fully characterized by elemental analysis, spectroscopic methods, and X-ray crystallography. At the technetium-99m (^99mTc) tracer level, the analogous complexes 3' and 4' were produced in high radiochemical purity, characterized by comparative reverse phase high-performance liquid chromatography and showed high resistance to transchelation by histidine or cysteine. This new [N,O][C][P] donor atom combination with the cis-[M(CO)₂]⁺ core (M = Re, ^99mTc) is a promising scaffold for the development of novel diagnostic and therapeutic targeted radiopharmaceuticals.

Crystal structure of fac-(acetylacetonato-κ2 O,O′)tricarbonyl(tri-m-tolyl phosphane-κP)rhenium(I), C29H28O5PRe

C29H28O5PRe, monoclinic, P21/n (no. 14), a = 10.548(5) Å, b = 22.996(5) Å, c = 11.022(5) Å, β = 98.011(5)°, V = 2647.4(18) Å3, Z = 4, R gt(F) = 0.0306, wRref (F2) = 0.0911, T = 100 K.

Crystal structure of fac-(acetylacetonato-κ2O,O′)tricarbonyl(tri(p-tolyl)phosphine-κP)rhenium(I), C29H28O5PRe

C29H28O5PRe, triclinic, P1̄ (no. 2), a = 12.733(7) Å, b = 18.668(11) Å, c = 24.779(15) Å, α = 101.442(20)°, β = 100.844(18)°, γ = 104.240(19)°, V = 5419(9) Å3, Z = 8, Rgt(F) = 0.0307, wRref(F2) = 0.0772, T = 100 K.

Crystal structure of fac-(acetylacetonato-κ2O,O′)tricarbonyl(benzyldiphenylphosphine-κP)rhenium(I), C27H24O5PRe

C27H24O5PRe, triclinic, P1̄ (no. 2), a = 9.0305(17) Å, b = 12.084(2) Å, c = 12.403(2) Å, α = 89.688(6)°, β = 70.083(6)°, γ = 76.315(6)°, V = 1232.2(4) Å3, Z = 2, Rgt(F) = 0.0180, wRref(F2) = 0.0432, T = 100(2) K.

Crystal structure of fac-tricarbon-yl(cyclo-hexyl isocyanide-κC)(quinoline-2-carboxyl-ato-κ(2) N,O)rhenium(I)

In the title compound, [Re(C10H6NO2)(C7H11N)(CO)3], the Re(I) atom is coordinated by three carbonyl ligands in a facial arrangement and by the N, O and C atoms from a chelating quinaldate anion and a monodentate isocyanide ligand, respectively. The resultant C4NO coordination sphere is distorted octa-hedral. A lengthening of the axial Re-CO bond trans to the isocyanide ligand is indicative of the trans effect. Individual complexes are stacked into rods parallel to [001] through displaced π-π inter-actions. Weak C-H⋯O hydrogen-bonding inter-actions between the rods lead to the formation of layers parallel to (010). These layers are stacked along [010] by C-H⋯H-C van der Waals contacts.

Synthesis and characterization of fac-[M(CO)3(P)(OO)] and cis-trans-[M(CO)2(P)2(OO)] complexes (M = Re, (99m)Tc) with acetylacetone and curcumin as OO donor bidentate ligands

The synthesis and characterization of neutral mixed ligand complexes fac-[M(CO)3(P)(OO)] and cis-trans-[M(CO)2(P)2(OO)] (M = Re, (99m)Tc), with deprotonated acetylacetone or curcumin as the OO donor bidentate ligands and a phosphine (triphenylphosphine or methyldiphenylphosphine) as the monodentate P ligand, is described. The complexes were synthesized through the corresponding fac-[M(CO)3(H2O)(OO)] (M = Re, (99m)Tc) intermediate aqua complex. In the presence of phosphine, replacement of the H2O molecule of the intermediate complex at room temperature generates the neutral tricarbonyl monophosphine fac-[Re(CO)3(P)(OO)] complex, while under reflux conditions further replacement of the trans to the phosphine carbonyl generates the new stable dicarbonyl bisphosphine complex cis-trans-[Re(CO)2(P)2(OO)]. The Re complexes were fully characterized by elemental analysis, spectroscopic methods, and X-ray crystallography showing a distorted octahedral geometry around Re. Both the monophosphine and the bisphosphine complexes of curcumin show selective binding to β-amyloid plaques of Alzheimer's disease. At the (99m)Tc tracer level, the same type of complexes, fac-[(99m)Tc(CO)3(P)(OO)] and cis-trans-[(99m)Tc(CO)2(P)2(OO)], are formed introducing new donor combinations for (99m)Tc(I). Overall, β-diketonate and phosphine constitute a versatile ligand combination for Re(I) and (99m)Tc(I), and the successful employment of the multipotent curcumin as β-diketone provides a solid example of the pharmacological potential of this system.

Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M=(99 m)Tc or Re)

A new tumor-seeking tridentate topology consisting of a phosphino dithioether ((HOCH(2))(2)PCH(2)CH(2)S(CH(2))(n)CH(2)SR; PS(2)) ligand framework for the production of kinetically inert and in vivo stable facial [(99m)Tc(CO)(3)(PS(2))](+) or [Re(CO)(3)(PS(2))](+) is described. The X-ray crystal structure of fac-Re(CO)(3)(PS(2))PF(6) is reported. The bioconjugation strategies for incorporating bombesin (BBN) peptides on to the PS(2) tripodal framework and, thereby, de novo designing of GRP receptor-seeking Tc(PS(2)-BBN)(CO)(3) are developed.

Curcumin as the OO bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications

The synthesis and characterization of "2 + 1" complexes of the [M(CO)(3)](+) (M = Re, (99m)Tc) core with the β-diketones acetylacetone (complexes 2, 8) and curcumin (complexes 5, 10 and 6, 11) as bidentate OO ligands, and imidazole or isocyanocyclohexane as monodentate ligands is reported. The complexes were synthesized by reacting the [NEt(4)](2)[Re(CO)(3)Br(3)] precursor with the β-diketone to generate the intermediate aqua complex fac-Re(CO)(3)(OO)(H(2)O) that was isolated and characterized, followed by replacement of the labile water by the monodentate ligand. All complexes were characterized by mass spectrometry, NMR and IR spectroscopies, and elemental analysis. In the case of complex 2, bearing imidazole as the monodentate ligand, X-ray analysis was possible. The chemistry was successfully transferred at (99m)Tc tracer level. The curcumin complexes 5 and 6, as well as their intermediate aqua complex 4, that bear potential for radiopharmaceutical applications due to the wide spectrum of pharmacological activity of curcumin, were successfully tested for selective staining of β-amyloid plaques of Alzheimer's disease. The fact that the complexes maintain the affinity of the mother compound curcumin for β-amyloid plaques prompts for further exploration of their chemistry and biological properties as radioimaging probes.